The risk and outcomes of pneumonia in patients on inhaled corticosteroids

Oriol Sibila, Natalia Soto-Gomez, Marcos I. Restrepo

Resultado de la investigación: Articlerevisión exhaustiva

15 Citas (Scopus)


Corticosteroids are frequently prescribed anti-inflammatory medications. Inhaled corticosteroids (ICS) are indicated for Chronic Obstructive Pulmonary Disease (COPD) and asthma. ICS are associated with a decrease in exacerbations and improved quality of life in COPD, however multiple studies have linked the chronic use of ICSs with an increased risk of developing pneumonia, though the effect on mortality is unclear. We review the association of ICS with the risk of pneumonia and the implications on clinical outcomes.

Idioma originalEnglish (US)
Páginas (desde-hasta)130-136
Número de páginas7
PublicaciónPulmonary Pharmacology and Therapeutics
EstadoPublished - jun 1 2015

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)


Profundice en los temas de investigación de 'The risk and outcomes of pneumonia in patients on inhaled corticosteroids'. En conjunto forman una huella única.

Citar esto